The antimicrobial resistance (AMR) diagnostics market is experiencing significant growth due to the rising prevalence of drug-resistant infections and the urgent need for rapid, accurate detection methods. Advances in molecular diagnostics, such as PCR and next-generation sequencing (NGS), are driving market expansion. Government initiatives, increased funding for AMR research, and growing awareness among healthcare professionals further support market growth.